.png)
The 16th Annual Drug Discovery Innovation Forum #DDIF
10th & 11th September 2025
The Hyatt Regency Barcelona Tower, Spain
Co-located
16th Annual Drug Discovery Innovation Forum 2025
10th & 11th September 2025
Co-located with The 8th Annual Cell & Gene Therapy Innovation Forum #CGTI
16th Annual Drug Discovery Innovation Forum 2025
Leaders shaping the future of drug discovery and beyond
KEYNOTES & ADVISORY
“Our very survival depends on our ability to stay awake, to adjust to new ideas, to remain vigilant and to face the challenge of change.” – Martin Luther King
For the patients, we must do better.
10th & 11th September 2025
Hyatt Regency Barcelona Tower, Spain
DDIF was formed 16 years ago and our mission remains the same - to push boundaries to affect change, for patients.
To continue this statement - drug discovery and development must evolve and innovate towards new modes of action. Embrace next-generation technology such as ML, AR, Generative AI, LLM and so forth. There is no avoiding it. To truly reduce drug discovery time and accelerate clinical trial development, we must advance towards digital transformation and break down silos and barriers we often create ourselves. More...
Werngard Czechtizky
Executive Director Head Medicinal Chemistry, Respiratory and Immunology at AstraZeneca
CONFIRMED SPEAKERS 2025
It's people, their stories and this momentum that inspires purpose
PREVIOUS SPEAKERS
2025 PROGRAMME SNAPSHOT
KEY TOPICS
-
Revolutionising Healthcare Through Digital Innovation
-
Harnessing AI and Cell Therapy: Transforming Cancer and Age-Related Disease Treatments
-
Patient-first AI Drug Discovery
-
Case-Studies in AI-Driven Discovery
-
A Novel and Differentiated Approach to Targeted Protein Degradation
-
Rise and impact of Quantum Computing
FIRESIDE CHAT
-
How can we ensure that AI and data in combination with other key technologies lead to better and more patient-centric drug discovery?
-
What are the examples where it worked and can we reflect on why it worked out to be a successful case?
-
Holistic approaches (all data, all knowledge, plus algorithms)
WHY & MISSION
For over 15 years we have followed some of the most prominent CXO's, thought leaders and great minds who help drive and shape the future of Drug Discovery. But what bring us together away from our silos? The mission is to advance and to make an impact towards a purpose that is necessary. For the patients, we must do better.
WHY ATTEND
Engage in thought-provoking discussions on challenges and opportunities facing the drug discovery industry
Revolutionize R&D through AI & Machine Learning
In-Person only attendance of up to 200 decision-makers
Maximise your time by taking part in our exclusive pre-qualified one-to-one networking service
Hear exclusively from renowned leaders presenting on challenges when leveraging digital technologies, artificial intelligence, and machine learning in your innovation cycle
Leveraging AI to unblock drug discovery, drug repurposing and target validation
Explore the latest advancements, breakthroughs, and innovative approaches in the quest for new drugs and therapies
Uncover novel therapeutics targets, drug candidates, and innovative approaches that can drive the development of life-changing treatments
Journey of a CXO - witness in person The Why? The journey and destination of some of the most inspirational CXO’s in the industry
"Our mission remains the same - deliver accurate, reliable and compelling content that equates to business partnerships and collaborations that impact better patients outcomes."
INNOVATION SPOTLIGHT
-
Revolutionising healthcare through Digital Innovation by Merck
-
Case-Studies in AI-Driven Drug Discovery by Insilico Medicine
-
Meeting Pharma Challenges Head-on with AI Innovation by Aion Labs
-
AI/ML and Drug Discovery: ab in silico ad humanum by Novartis
WHY ATTEND
-
Closed door gatherings
-
Form strategic partnerships
-
Collaborate and transform ideas into meaningful outcomes, for the patients
VENDOR FOCUS
-
Digital transformation
-
Bioinformatics
-
Big data analytics and integration
-
End to end biologic workflows
-
AI-powered target identification
-
Integrated Drug Discovery
-
Out sourcing
-
CRO
-
Clinical Data Solutions
Type of Job Titles Attending:
-
CEO
-
CSO
-
CTO
-
CIO
-
EVP/SVP/VP
-
Director
Type of Companies Attending:
-
Pharmaceutical Organizations
-
Pharma and Research Institutions
-
Contract Development and Manufacturing Organizations
-
Government and Regulatory Agencies
-
Biotech Companies
-
Drug Discovery Solution Providers
-
Digital health and software providers
-
Logistics and supply chain companies
How CAN WE really use AI to advance drug discovery?
An invite only assembly of up to 200 leaders committed in making an impact.
200+
Up to 200 decision-makers in person. Previous attendee demographics include 50% EMEA, 30% America and 20% ROW
20%
20% best-of-breed vendors supporting the drug discovery industry
06
Journey of CXO presentations. Six insightful, powerful and inspirational talks from CXOs in the industry
02
Exclusive in-person networking, over 2 days in Barcelona 2025
7+
Pre-scheduled and pre-qualified one-to-one meetings with delegates who can either influence or make a decision
90%
Over 90% of our attendance provided positive feedback. Please click here to see what our delegation has to say
THE NUMBERS
DDIF
